RESUMO
OBJECTIVES: Systemic sclerosis (SSc) is heterogenous. The objectives of this study were to evaluate the purpose, strengths and limitations of existing SSc subset criteria, and identify ideas among experts about subsets. METHODS: We conducted semi-structured interviews with randomly sampled international SSc experts. The interview transcripts underwent an iterative process with text deconstructed to single thought units until a saturated conceptual framework with coding was achieved and respondent occurrence tabulated. Serial cross-referential analyses of clusters were developed. RESULTS: Thirty experts from 13 countries were included; 67% were male, 63% were from Europe and 37% from North America; median experience of 22.5 years, with a median of 55 new SSc patients annually. Three thematic clusters regarding subsetting were identified: research and communication; management; and prognosis (prediction of internal organ involvement, survival). The strength of the limited/diffuse system was its ease of use, however 10% stated this system had marginal value. Shortcomings of the diffuse/limited classification were the risk of misclassification, predictions/generalizations did not always hold true, and that the elbow or knee threshold was arbitrary. Eighty-seven percent use more than 2 subsets including: SSc sine scleroderma, overlap conditions, antibody-determined subsets, speed of progression, and age of onset (juvenile, elderly). CONCLUSIONS: We have synthesized an international view of the construct of SSc subsets in the modern era. We found a number of factors underlying the construct of SSc subsets. Considerations for the next phase include rate of change and hierarchal clustering (e.g. limited/diffuse, then by antibodies).
Assuntos
Medição de Risco/métodos , Escleroderma Sistêmico/diagnóstico , Adulto , Estudos Transversais , Progressão da Doença , Feminino , Humanos , Masculino , PrognósticoRESUMO
Raynaud's phenomenon (RP) is a functional vascular disorder involving extremities. In his practice, the dermatologist may frequently encounter RP which affects mainly women and is categorized into a primary benign form and a secondary form associated with different diseases (infections, drugs, autoimmune and vascular conditions, haematologic, rheumatologic and endocrinologic disorders). Still today, the differential diagnosis is a clinical challenge. Therefore, a careful history and a physical examination, together with laboratory tests and nailfold capillaroscopy, is mandatory. RP is generally benign, but a scheduled follow-up for primary RP patients should be established, due to risk of evolution to secondary RP. A combination of conservative measures and medications can help in the management of RP. The importance of avoiding all potential physical, chemical and emotional triggers, as well as quitting smoking, should be strongly suggested to the patient. As first-line treatment, dihydropyridine calcium channel blockers should be used. If this approach is not sufficient, prostacyclin derivatives, phosphodiesterases inhibitors and endothelin receptor antagonists can be considered as second-line treatment. In cases of acute ischaemia, nifedipine and intravenous prostanoids are helpful. In refractory cases, botulinum injections have shown a significant benefit. The approach to the RP patients requires therefore a coordinated care of specialists together with the primary care physician.
Assuntos
Dermatologia , Dedos/patologia , Papel do Médico , Doença de Raynaud/diagnóstico , Doença de Raynaud/terapia , Gangrena/prevenção & controle , Humanos , Isquemia/diagnóstico , Isquemia/tratamento farmacológico , Isquemia/etiologia , Angioscopia Microscópica , Necrose/prevenção & controle , Doença de Raynaud/complicações , Doença de Raynaud/diagnóstico por imagemRESUMO
Vascular endothelial injury in SSc leads to a host of pathological changes in the blood vessels that adversely impact the physiology of many organ systems and eventually results in a state of chronic tissue ischaemia. Current hypotheses in SSc vascular disease pathogenesis suggest a possible infectious or chemical trigger(s) that activates both cellular and humoral immunity. Products of immune activation may lead to vascular injury possibly through the production of autoantibodies and the release of products of activated T cells that can directly damage the endothelium. Knowledge of the initial trigger of immune activation in SSc may offer an opportunity to develop a multiple step strategy for therapeutic intervention.
Assuntos
Endotélio Vascular/patologia , Escleroderma Sistêmico/patologia , Apoptose , Autoanticorpos/imunologia , Doenças Autoimunes/imunologia , Doenças Autoimunes/patologia , Citomegalovirus , Infecções por Citomegalovirus/imunologia , Infecções por Citomegalovirus/patologia , Endotélio Vascular/imunologia , Fibrose , Humanos , Traumatismo por Reperfusão/imunologia , Traumatismo por Reperfusão/patologia , Escleroderma Sistêmico/imunologia , Linfócitos T Citotóxicos/imunologiaRESUMO
Our objective was to identify a core set of variables for the assessment of vascular involvement in scleroderma that is simple, reproducible, and reflects the presence of vascular disease in SSc. To do so we carried out an extensive literature review of published studies relating to the assessment of vascular involvement in SSc, i.e. studies dealing with clinical parameters, functional vascular studies, cold presser testing, nailfold capillary microscopy and circulating vascular markers. After extensive review of published studies and critical assessment of proposed vascular parameters, the subcommittee endorsed what it considers to be the minimal requirements for the documentation of vascular involvement in SSc. The core set variables include two parameters: Raynaud's phenomenon and digital ulcers. This set is simple, reproducible and should be included in the assessment of SSc patients in clinical investigational studies. The subcommittee also however recognizes that there exists a promising set of vascular variable that still needs further investigation.
Assuntos
Escleroderma Sistêmico/diagnóstico , Doenças Vasculares/diagnóstico , Vasos Sanguíneos/patologia , Humanos , Reumatologia/métodos , Reumatologia/normas , Escleroderma Sistêmico/complicações , Pele/irrigação sanguínea , Doenças Vasculares/etiologiaRESUMO
The pathogenesis of vasculitides is poorly understood. A growing body of evidence indicates that endothelium injury is a fundamental step in the development of all types of vasculitides. In the recent years, it has become evident that endothelial cell is responsible for a multiplicity of functions such as several immunological activities and the control of the vascular tone. The alteration of endothelium may result in metabolic and biologic disorders leading to pathologic changes. Even though the importance of endothelial cell is now demonstrated, the pathophysiological mechanisms able to induce the vascular damage are still not completely defined. In the next years, the better knowledge of the physiology of the endothelium might lead to a more appropriate therapy of vasculitis.
Assuntos
Endotélio Vascular/patologia , Vasculite/etiologia , Endotélio Vascular/imunologia , Endotélio Vascular/metabolismo , Humanos , Vasculite/metabolismo , Vasculite/patologiaRESUMO
In systemic sclerosis, the exaggerated generalized vasospastic tendency is clinically represented by Raynaud's phenomenon as shown by an early digital arterial closure after cold stimulation, and by an inadequate vasodilatory response to heat. The phenomenon is not restricted to the extremities, and can also occur in internal organs. Repeated attacks of Raynaud's phenomenon may contribute to vascular disease in systemic sclerosis by a mechanism of reperfusion injury of the endothelium, and may contribute to tissue fibrosis. Although the aetiology and pathogenesis of Raynaud's phenomenon remain unknown, recent advances in the understanding of mechanisms of vascular tone control provide us with an opportunity to reconsider the pathogenetic process of Raynaud's phenomenon. It is now clear that neuropeptides, the vascular endothelium, and platelets are the three major contributors to the control of vascular tone. Our hypothesis suggests the presence of a sensory nervous system failure, leading to an unopposed endothelial and platelet control of vascular tone. Endothelial injury and platelet activation in systemic sclerosis lead to a shift in vascular function to a pro-vasospastic function not balanced by a vasodilatory sensory input; thus, enhanced vasospasm is generated. The investigation of the role of local vascular mediators in vasospasm may lead to a better understanding of vascular tone control and of Raynaud's phenomenon pathophysiology in systemic sclerosis.
Assuntos
Doença de Raynaud/etiologia , Escleroderma Sistêmico/complicações , Humanos , Prevalência , Doença de Raynaud/classificação , Doença de Raynaud/diagnóstico , Doença de Raynaud/epidemiologia , Doença de Raynaud/fisiopatologiaRESUMO
Now that the immune involvement in scleroderma is well established, attention is focused on defining the precise mechanisms in immune activation, the nature of autoantigens, the clinical description of disease subsets as defined by autoantibodies, the cytokine network, and the participation of various immune cells in the disease. Yet the exact trigger of immune involvement is still elusive. Interaction of immune cells with the vascular endothelium, through cell-cell interactions and the effect of cytokines, is one of the earliest changes in scleroderma. It is still unclear whether immune alteration follows or precedes endothelial changes. Nonetheless, involvement of the adhesion molecules cascade is well documented. A nucleolar location has been suggested for all of the major autoantigens in scleroderma, with the nucleolus as the primary autoantigen molecular structure. Topoisomerase-I homology to viral proteins continues to be the focus of investigation; however, molecular mimicry in scleroderma autoimmunity is still unproven. Enhanced expression and responses to interleukin-1 and interleukin-6 by scleroderma fibroblasts emphasize the interactive nature of fibroblasts and demonstrate the ability of nonimmune cells to produce immune mediators. Circulating autoantibodies to interleukin-6 and interleukin-8 add another dimension to our understanding of cytokine network regulation in scleroderma. Circulating markers reflecting T-cell activation in vivo continue to be observed. Adenosine deaminase is the most recent indicator described. Nonetheless, the exact phenotype of the principal effector T cell in scleroderma is still not known. A restricted usage of the V beta gene repertoire of the double-negative alpha/beta T cells propose this cell type as the alloreactive cell in scleroderma.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Autoanticorpos/sangue , Citocinas/sangue , Escleroderma Sistêmico/imunologia , Linfócitos T/imunologia , Humanos , Ativação Linfocitária , Escleroderma Sistêmico/sangue , Escleroderma Sistêmico/patologiaRESUMO
An elevated level of von Willebrand factor (vWf) is a well-established marker for both in vivo and in vitro endothelial cell injury. Recent studies indicate that the plasma level of angiotensin-converting enzyme (ACE) in systemic sclerosis is reduced in association with elevated vWf levels. Because the endothelial cell is capable of producing both mediators, and because endothelial cell injury is a fundamental process in systemic sclerosis, we investigated in this study the effect of in vitro endothelial cell injury on the synthesis of both factors. Endothelial cells derived from human umbilical veins, in the second passage, were activated by exposure to interleukin-1 or lymphotoxin or were injured by radiation, actinomycin, or trypsin (each can be shown to induce dose-dependent endothelial cell cytotoxicity). ACE (spectrophotometric method) and vWf levels (enzyme-linked immunosorbent assay method) were determined in the supernatant and in the cell lysate 48 hours after cellular injury and activation. An increase in vWf levels was found in the lysate and in the supernatant from the cells that underwent injury or activation, whereas ACE levels were increased after activation but decreased after injury. Next, and as an in vivo clinical corollary to the in vitro endothelial cell injury, we evaluated ACE and vWf levels in the plasma of seven children in the acute phase of Kawasaki disease, a disorder characterized by widespread vascular injury. Plasma ACE levels were significantly lower than control levels, whereas vWf levels were increased, reflecting the known prominent endothelial cell injury in this disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Peptidil Dipeptidase A/biossíntese , Células Cultivadas , Criança , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/efeitos da radiação , Humanos , Interleucina-1/farmacologia , Linfotoxina-alfa/farmacologia , Síndrome de Linfonodos Mucocutâneos/sangue , Síndrome de Linfonodos Mucocutâneos/enzimologia , Peptidil Dipeptidase A/efeitos dos fármacos , Peptidil Dipeptidase A/efeitos da radiação , Veias Umbilicais/metabolismo , Veias Umbilicais/patologia , Fator de von Willebrand/biossínteseRESUMO
OBJECTIVE: To describe the clinical, radiologic, and pathologic features of coexistent systemic sclerosis (SSc) and sarcoidosis, 2 conditions of unknown cause associated with altered cellular immune response. METHODS: We reviewed clinical information, results from laboratory and radiologic studies, and lung or lymph node biopsy samples of 7 patients with concurrent SSc and sarcoidosis evaluated at 2 academic referral centers between 1989 and 1993. RESULTS: Each patient fulfilled American College of Rheumatology criteria for the classification of SSc. SSc and sarcoidosis developed simultaneously in 4 patients, whereas in 3 others sarcoidosis was diagnosed more than 6 years after the onset of SSc. The onset of sarcoidosis was characterized by fever, weight loss, or increasing respiratory symptoms. Each patient had radiographic evidence of intrathoracic lymphadenopathy and/or interstitial lung disease. Examination of lung or lymph node biopsies demonstrated noncaseating granulomas. Treatment with corticosteroids was associated with improved lung function. CONCLUSION: Since sarcoidosis coexists with SSc more frequently than previously suggested, it should be considered in patients with SSc presenting with new pulmonary symptoms. Recognizing sarcoidosis in patients with SSc is important, since these patients may benefit from corticosteroid therapy.
Assuntos
Sarcoidose/complicações , Escleroderma Sistêmico/complicações , Corticosteroides/uso terapêutico , Adulto , Idoso , Biópsia , Feminino , Granuloma/complicações , Humanos , Doenças Pulmonares Intersticiais/complicações , Masculino , Pessoa de Meia-Idade , Radiografia , Sarcoidose/diagnóstico por imagem , Sarcoidose/tratamento farmacológico , Escleroderma Sistêmico/diagnóstico por imagem , Escleroderma Sistêmico/tratamento farmacológicoRESUMO
Recent evidence suggests that a key feature in the pathogenesis of hypertrophic osteoarthropathy (HOA) is an enhanced local platelet vessel wall interaction in the affected extremities. In our investigation we measured plasma levels of von Willebrand Factor Antigen (vWF:Ag; ELISA assay), a marker of platelet and/or endothelial activation, in 5 patients with the primary form of HOA and in 6 patients with the secondary form (due to cyanotic heart disease). Seven subjects matched for sex and age were used as controls. Patients showed statistically significantly higher levels of vWF:Ag in the primary (163.8 +/- 13.9%) and secondary form (152.6 +/- 9.6%, p less than 0.001 for both) when compared to controls (100.4 +/- 6.3%). Our results support the notion that platelet endothelial cell interaction may play a key role in the development of HOA.
Assuntos
Antígenos/análise , Osteoartropatia Hipertrófica Primária/imunologia , Adolescente , Adulto , Criança , Endotélio Vascular/patologia , Ensaio de Imunoadsorção Enzimática , Humanos , Masculino , Osteoartropatia Hipertrófica Primária/sangue , Osteoartropatia Hipertrófica Primária/etiologia , Estatística como Assunto , Fator de von Willebrand/imunologiaRESUMO
We have developed a method for the detection of immune complexes by laser nephelometry which is simple, reproducible, suitable for automation, and generally adaptable for diagnostic testing. Light dispersion by antigen-antibody complexes in the test samples is measured after addition of polymeric buffer, which enhances the aggregation of complexes but does not significantly affect unbound immunoglobulins. The method was used to measure immune complexes formed in vitro by incubation of tetanus toxoid with serum from a rabbit previously hyperimmunized with the same antigen, and to compare the levels of immune complexes in human sera obtained from normal adults and from 37 patients with collagen vascular diseases or endocarditis. When precautions were taken to avoid interference produced by the presence of lipoproteins or by freezing of the samples, the results obtained with human sera were consistent with those expected for normal controls and for patients with conditions thought to be associated with the presence of soluble immune complexes.
Assuntos
Complexo Antígeno-Anticorpo , Animais , Artrite Reumatoide/imunologia , Sítios de Ligação , Complemento C1 , Endocardite Bacteriana/imunologia , Humanos , Imunoglobulina G , Luz , Lúpus Eritematoso Sistêmico/imunologia , Coelhos , Espalhamento de Radiação , Solubilidade , SuspensõesRESUMO
OBJECTIVE: To determine the circulating levels of nerve growth factor (NGF), neuropeptide Y (NPY), and vasoactive intestinal peptide (VIP) in systemic sclerosis (SSc), and to correlate these levels with clinical and laboratory features. METHODS: Forty four patients with SSc were evaluated for circulating NGF (immunoenzymatic assay), NPY and VIP (radioimmunoassay), anticentromere and antitopoisomerase I autoantibodies, lung disease (pulmonary function tests with carbon monoxide transfer factor (TLCO), ventilation scintiscan with 99mTc DTPA radioaerosol, high resolution computed tomography (HRCT), pulmonary pressure (echo colour Doppler)), heart disease (standard and 24 ECG, echocardiography), cutaneous involvement (skin score), joint involvement (evidence of tender or swollen joints, or both), peripheral nervous system (PNS) involvement (electromyography), rheumatoid factor, angiotensin converting enzyme (fluorimetric method), von Willebrand factor (ELISA), and erythrocyte sedimentation rate (ESR) (Westergren). RESULTS: Circulating NGF levels in SSc were significantly increased compared with controls (p<0.00001) and significantly higher in the diffuse than in the limited subset of patients (p<0.01). Patients with articular disease had significantly higher levels of NGF. A significant indirect correlation between NGF levels and TLCO was detected (p<0.01), but no correlation was found between NGF and HRCT, DTPA, skin score, PNS involvement and angiotensin converting enzyme and von Willebrand factor levels, antitopoisomerase or anticentromere antibodies, and ESR. NGF levels increased progressively as the disease worsened. Similarly, VIP circulating levels were significantly increased in patients with SSc (p<0.001), whereas the increase of NPY levels did not reach statistical significance. However, both neuropeptides, following the same trend as NGF, increased as the disease worsened (skin score and lung disease). CONCLUSIONS: The increase of NGF and VIP in patients with SSc, the former in the diffuse subset of the disease, and in patients with prominent articular disease, may suggest a link between neurotransmitters and the disease pathogenesis. Neuropeptide circulating levels seem to increase only in patients with the most severe disease.